{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T20:49:59Z","timestamp":1790369399828,"version":"4.1.0"},"reference-count":42,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Med Internet Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec sec-type=\"background\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Previous research has demonstrated that the use of continuous glucose monitoring (CGM) can improve glycemic control in people with type 2 diabetes when used regularly alongside a digital diabetes self-management education and support (DSMES) program. However, to date, there is limited evidence showing the benefits of a digitally delivered DSMES program combined with real-time CGM for adults with type 2 diabetes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"objective\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      The objective of this study is to evaluate the impact of a DSMES program coupled with CGM on hemoglobin A\n                      <jats:sub>1c<\/jats:sub>\n                      (HbA\n                      <jats:sub>1c<\/jats:sub>\n                      ) and CGM-derived glycemic measures compared to usual care for adults with type 2 diabetes over 6 months.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"methods\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Participants with type 2 diabetes and HbA\n                      <jats:sub>1c<\/jats:sub>\n                      of 8% or higher (64 mmol\/mol) who were not using mealtime bolus insulin (aged 26\u201083 y; mean HbA\n                      <jats:sub>1c<\/jats:sub>\n                      9.6%, SD 1.4% [mean 81.2 mmol\/mol, SD 15.8 mmol\/mol]) were randomly assigned to a digital DSMES+CGM integrated solution (n=51) or usual care (n=49) for 6 months. The primary outcome was HbA\n                      <jats:sub>1c<\/jats:sub>\n                      . The secondary outcomes were CGM-derived glycemic measures, including glucose management indicator, percent time in range 70 to 180 mg\/dL, percent time above range (&gt;180 mg\/dL), percent time below range (&lt;70 mg\/dL), and mean glucose. Linear mixed effects models were used for intention-to-treat analyses.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"results\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      HbA\n                      <jats:sub>1c<\/jats:sub>\n                      was lower among the intervention group versus the usual care group at 3 months (difference=\u22120.7%, 95% CI \u22121.4% to \u22120.1% or difference=\u22128.1 mmol\/mol, 95% CI \u221215.5 to \u22120.7 mmol\/mol;\n                      <jats:italic>P<\/jats:italic>\n                      =.03) and at 6 months (difference=\u22120.6%, 95% CI \u22121.4% to 0.2% or difference=\u22126.9 mmol\/mol, 95% CI \u221215.7 to 1.9 mmol\/mol;\n                      <jats:italic>P<\/jats:italic>\n                      =.12) but only reached statistical significance at 3 months. CGM-derived glycemic measures, including glucose management indicator (difference=\u22120.9%, 95% CI \u22121.7% to \u22120.1%;\n                      <jats:italic>P<\/jats:italic>\n                      =.03), time in range (difference=14.6%, 95% CI 1.0% to 28.2%;\n                      <jats:italic>P<\/jats:italic>\n                      =.04), time above range (difference=\u221214.9%, 95% CI \u221229.0% to \u22120.9%;\n                      <jats:italic>P<\/jats:italic>\n                      =.04), and mean glucose (difference=\u221236.4 mg\/dL, 95% CI \u221270.0 to \u22122.9 mg\/dL;\n                      <jats:italic>P<\/jats:italic>\n                      =.03), also significantly improved for the intervention group versus the usual care group at 6 months.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"conclusions\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The combination of digital DSMES+CGM is effective for supporting adults with type 2 diabetes in managing their condition and has the potential to reduce the risk of long-term health complications.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2196\/78321","type":"journal-article","created":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T13:55:07Z","timestamp":1776002107000},"page":"e78321-e78321","source":"Crossref","is-referenced-by-count":1,"title":["A Digital Diabetes Self-Management Education and Support Program Integrated With Continuous Glucose Monitoring for Type 2 Diabetes: Randomized Controlled Trial"],"prefix":"10.2196","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5269-2924","authenticated-orcid":false,"given":"Ashley","family":"Berthoumieux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7014-2990","authenticated-orcid":false,"given":"Jeanean B","family":"Naqvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0802-2066","authenticated-orcid":false,"given":"Sean","family":"Zion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0271-5937","authenticated-orcid":false,"given":"Jenna","family":"Napoleone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6257-3793","authenticated-orcid":false,"given":"Amanda","family":"McGuill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2160-3148","authenticated-orcid":false,"given":"Christian J","family":"Cerrada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8105-821X","authenticated-orcid":false,"given":"Hyun Jung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3487-2504","authenticated-orcid":false,"given":"Timothy C","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1335-1857","authenticated-orcid":false,"given":"David","family":"Kerr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3819-670X","authenticated-orcid":false,"given":"Carolyn Bradner","family":"Jasik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7129-3416","authenticated-orcid":false,"given":"Sarah","family":"Linke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2026,5,14]]},"reference":[{"issue":"Suppl 1","key":"R1","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.2337\/dc24-S002","article-title":"2. Diagnosis and classification of diabetes: standards of care in diabetes-2024","volume":"47","author":"American Diabetes Association Professional Practice Committee","journal-title":"Diabetes Care"},{"issue":"4","key":"R2","doi-asserted-by":"publisher","first-page":"249","DOI":"10.2174\/1573403X1604201229115531","article-title":"Complications of the type 2 diabetes mellitus","volume":"16","author":"Farmaki","journal-title":"Curr Cardiol Rev"},{"key":"R3","unstructured":"Type 2 diabetes. Centers for Disease Control and Prevention (CDC). 2023. URL: https:\/\/www.cdc.gov\/diabetes\/about\/about-type-2-diabetes.html [Accessed 24-04-2024]"},{"issue":"6","key":"R4","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/j.pec.2015.11.003","article-title":"Diabetes self-management education for adults with type 2 diabetes mellitus: a systematic review of the effect on glycemic control","volume":"99","author":"Chrvala","journal-title":"Patient Educ Couns"},{"issue":"2","key":"R5","doi-asserted-by":"publisher","first-page":"484","DOI":"10.2337\/dc21-2396","article-title":"2022 National standards for diabetes self-management education and support","volume":"45","author":"Davis","journal-title":"Diabetes Care"},{"key":"R6","doi-asserted-by":"crossref","unstructured":"Veazie S Winchell K Gilbert J et al. Mobile health applications for self-management of diabetes. Agency for Healthcare Research and Quality (US); 2018. URL: https:\/\/effectivehealthcare.ahrq.gov\/sites\/default\/files\/pdf\/technical-brief-31_mobile-health-applications-for-self-management-of-diabetes.pdf [Accessed 24-04-2026]","DOI":"10.23970\/AHRQEPCTB31"},{"key":"R7","unstructured":"Improving access to diabetes education. Centers for Disease Control and Prevention (CDC). 2022. URL: https:\/\/www.cdc.gov\/diabetes\/health-equity\/improving-access-education.html [Accessed 19-04-2024]"},{"issue":"5","key":"R8","doi-asserted-by":"publisher","first-page":"429","DOI":"10.2337\/cd20-0043","article-title":"Using continuous glucose monitoring in clinical practice","volume":"38","author":"Miller","journal-title":"Clin Diabetes"},{"issue":"4","key":"R9","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1177\/1932296816628547","article-title":"The cost-effectiveness of real-time continuous glucose monitoring (RT-CGM) in type 2 diabetes","volume":"10","author":"Fonda","journal-title":"J Diabetes Sci Technol"},{"issue":"1","key":"R10","doi-asserted-by":"publisher","DOI":"10.1186\/s13098-023-01208-5","article-title":"Cost-effectiveness of continuous glucose monitoring with FreeStyle Libre in Brazilian insulin-treated patients with types 1 and 2 diabetes mellitus","volume":"15","author":"Bahia","journal-title":"Diabetol Metab Syndr"},{"issue":"6","key":"R11","doi-asserted-by":"publisher","DOI":"10.1002\/edm2.369","article-title":"A systematic review: cost-effectiveness of continuous glucose monitoring compared to self-monitoring of blood glucose in type 1 diabetes","volume":"5","author":"Jiao","journal-title":"Endocrinol Diabetes Metab"},{"issue":"Supplement_1","key":"R12","doi-asserted-by":"publisher","first-page":"S97","DOI":"10.2337\/dc22-S007","article-title":"7. Diabetes technology: standards of medical care in diabetes-2022","volume":"45","author":"American Diabetes Association Professional Practice Committee","journal-title":"Diabetes Care"},{"issue":"3","key":"R13","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.diabres.2008.01.006","article-title":"Continuous glucose monitoring counseling improves physical activity behaviors of individuals with type 2 diabetes: a randomized clinical trial","volume":"80","author":"Allen","journal-title":"Diabetes Res Clin Pract"},{"issue":"3","key":"R14","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/j.1365-2702.2008.02533.x","article-title":"Feasibility and acceptability of continuous glucose monitoring and accelerometer technology in exercising individuals with type 2 diabetes","volume":"18","author":"Allen","journal-title":"J Clin Nurs"},{"issue":"4","key":"R15","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1111\/dom.14949","article-title":"IMpact of flash glucose Monitoring in pEople with type 2 diabetes inadequately controlled with non-insulin antihyperglycaemic thErapy (IMMEDIATE): a randomized controlled trial","volume":"25","author":"Aronson","journal-title":"Diabetes Obes Metab"},{"issue":"3","key":"R16","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1089\/dia.2022.0419","article-title":"The AH-HA! Project: transforming group diabetes self-management education through the addition of flash glucose monitoring","volume":"25","author":"Polonsky","journal-title":"Diabetes Technol Ther"},{"issue":"5","key":"R17","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1177\/1932296819888662","article-title":"A virtual type 2 diabetes clinic using continuous glucose monitoring and endocrinology visits","volume":"14","author":"Dixon","journal-title":"J Diabetes Sci Technol"},{"issue":"2","key":"R18","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1089\/dia.2020.0396","article-title":"Remote application and use of real-time continuous glucose monitoring by adults with type 2 diabetes in a virtual diabetes clinic","volume":"23","author":"Bergenstal","journal-title":"Diabetes Technol Ther"},{"issue":"7","key":"R19","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1089\/tmj.2018.0128","article-title":"Clinical effectiveness of telemedicine in diabetes mellitus: a meta-analysis of 42 randomized controlled trials","volume":"25","author":"Tchero","journal-title":"Telemed J E Health"},{"issue":"9","key":"R20","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1080\/13696998.2019.1609483","article-title":"Reduced medical spending associated with increased use of a remote diabetes management program and lower mean blood glucose values","volume":"22","author":"Whaley","journal-title":"J Med Econ"},{"issue":"6","key":"R21","doi-asserted-by":"publisher","DOI":"10.2196\/jmir.9225","article-title":"Evaluation of a diabetes self-management program: claims analysis on comorbid illnesses, health care utilization, and cost","volume":"20","author":"Turner","journal-title":"J Med Internet Res"},{"issue":"2","key":"R22","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1089\/dia.2020.0375","article-title":"The digital\/virtual diabetes clinic: the future is now-recommendations from an international panel on diabetes digital technologies introduction","volume":"23","author":"Phillip","journal-title":"Diabetes Technol Ther"},{"issue":"12","key":"R23","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1111\/imj.14738","article-title":"Clinical efficacy and plausibility of a smartphone-based integrated online real-time diabetes care system via glucose and diet data management: a pilot study","volume":"50","author":"Ku","journal-title":"Intern Med J"},{"issue":"2","key":"R24","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s13300-018-0373-9","article-title":"Effectiveness and safety of a novel care model for the management of type 2 diabetes at 1 year: an open-label, non-randomized, controlled study","volume":"9","author":"Hallberg","journal-title":"Diabetes Ther"},{"key":"R25","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00348","article-title":"Long-term effects of a novel continuous remote care intervention including nutritional ketosis for the management of type 2 diabetes: a 2-year non-randomized clinical trial","volume":"10","author":"Athinarayanan","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"R26","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1177\/26350106231221456","article-title":"Long-term results of a digital diabetes self-management and education support program among adults with type 2 diabetes: a retrospective cohort study","volume":"50","author":"Berthoumieux","journal-title":"Sci Diabetes Self Manag Care"},{"issue":"3","key":"R27","doi-asserted-by":"publisher","first-page":"626","DOI":"10.2337\/diacare.28.3.626","article-title":"Assessing psychosocial distress in diabetes: development of the diabetes distress scale","volume":"28","author":"Polonsky","journal-title":"Diabetes Care"},{"issue":"16","key":"R28","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1056\/NEJMoa2205650","article-title":"Intermittently scanned continuous glucose monitoring for type 1 diabetes","volume":"387","author":"Leelarathna","journal-title":"N Engl J Med"},{"key":"R29","unstructured":"R: a language and environment for statistical computing. R Foundation for Statistical Computing. 2023. URL: https:\/\/www.R-project.org\/ [Accessed 24-04-2026]"},{"key":"R30","doi-asserted-by":"crossref","unstructured":"Chakraborty H Gu H . A mixed model approach for intent-to-treat analysis in longitudinal clinical trials with missing values. RTI Press; 2009. URL: https:\/\/www.rti.org\/rti-press-publication\/mixed-model-approach-intent-treat-analysis-longitudinal-clinical-trials-missing-values\/fulltext.pdf [Accessed 24-04-2026]","DOI":"10.3768\/rtipress.2009.mr.0009.0903"},{"issue":"404","key":"R31","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1080\/01621459.1988.10478722","article-title":"A test of missing completely at random for multivariate data with missing values","volume":"83","author":"Little","journal-title":"J Am Stat Assoc"},{"issue":"3","key":"R32","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.jml.2012.11.001","article-title":"Random effects structure for confirmatory hypothesis testing: keep it maximal","volume":"68","author":"Barr","journal-title":"J Mem Lang"},{"issue":"2","key":"R33","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1373\/clinchem.2010.148841","article-title":"Status of hemoglobin A1c measurement and goals for improvement: from chaos to order for improving diabetes care","volume":"57","author":"Little","journal-title":"Clin Chem"},{"issue":"7258","key":"R34","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1136\/bmj.321.7258.405","article-title":"Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study","volume":"321","author":"Stratton","journal-title":"BMJ"},{"issue":"3","key":"R35","doi-asserted-by":"publisher","first-page":"400","DOI":"10.2337\/dc18-1444","article-title":"Validation of time in range as an outcome measure for diabetes clinical trials","volume":"42","author":"Beck","journal-title":"Diabetes Care"},{"issue":"1","key":"R36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1297\/cpe.30.1","article-title":"Time in range centered diabetes care","volume":"30","author":"Dovc","journal-title":"Clin Pediatr Endocrinol"},{"issue":"6","key":"R37","doi-asserted-by":"publisher","first-page":"e2221","DOI":"10.1210\/clinem\/dgac034","article-title":"Complications of diabetes and metrics of glycemic management derived from continuous glucose monitoring","volume":"107","author":"Yapanis","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"R38","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1177\/193229681100500320","article-title":"The effect of real-time continuous glucose monitoring on glycemic control in patients with type 2 diabetes mellitus","volume":"5","author":"Ehrhardt","journal-title":"J Diabetes Sci Technol"},{"issue":"4","key":"R39","first-page":"253","volume":"11","author":"Choe","journal-title":"Am J Manag Care"},{"issue":"1","key":"R40","doi-asserted-by":"publisher","DOI":"10.2196\/25295","article-title":"Early insights from a digitally enhanced diabetes self-management education and support program: single-arm nonrandomized trial","volume":"6","author":"Wilson-Anumudu","journal-title":"JMIR Diabetes"},{"issue":"2","key":"R41","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s40290-024-00518-x","article-title":"Decentralisation in clinical trials and patient centricity: benefits and challenges","volume":"38","author":"Sinha","journal-title":"Pharmaceut Med"},{"issue":"4","key":"R42","first-page":"225","volume":"38","author":"Alexander","journal-title":"P T"}],"container-title":["Journal of Medical Internet Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jmir.org\/2026\/1\/e78321","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T18:10:54Z","timestamp":1782843054000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jmir.org\/2026\/1\/e78321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,14]]},"references-count":42,"URL":"https:\/\/doi.org\/10.2196\/78321","relation":{},"ISSN":["1438-8871"],"issn-type":[{"value":"1438-8871","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,14]]},"article-number":"v28iSuppl 1e78321"}}